+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Spinal Imaging Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083823
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Spinal Imaging Market grew from USD 2.78 billion in 2024 to USD 3.14 billion in 2025. It is expected to continue growing at a CAGR of 12.75%, reaching USD 5.73 billion by 2030.

The spinal imaging market stands at a pivotal juncture. Driven by an aging global population, rising prevalence of degenerative and congenital spinal disorders, and advancements in precision diagnostics, demand for comprehensive imaging solutions has never been greater. Clinicians and healthcare providers are under mounting pressure to improve diagnostic accuracy and streamline care pathways, while navigating complex regulatory and reimbursement environments. As technology converges with clinical need, stakeholders must grasp emerging trends, supply-chain dynamics, and competitive strategies to maintain a leadership position.

This executive summary distills key insights from the latest industry research. It explores transformative shifts reshaping the landscape, assesses policy impacts such as newly imposed tariffs in the United States, and highlights segmentation patterns across instrumentation, clinical applications, and end-user settings. Regional nuances and competitive positioning among leading manufacturers are examined, culminating in actionable recommendations designed to guide strategic decision-making. By the end of this overview, readers will gain a clear, authoritative perspective on the forces shaping spinal imaging’s future and the pathways for capturing value in a rapidly evolving environment.

Transformative Shifts Redefining the Spinal Imaging Landscape

The spinal imaging sector has undergone transformative changes over the past several years, driven by breakthroughs in hybrid modalities and digital integration. AI-enabled diagnostic algorithms are now augmenting radiologist workflows, improving lesion detection in complex spinal anatomy. Furthermore, the rise of hybrid imaging platforms that fuse PET and MRI data is delivering unparalleled soft-tissue contrast alongside metabolic insights, reshaping oncology and infection assessment protocols.

Another notable shift is the resurgence of low-field power MRI systems, which offer reduced operational costs and less stringent siting requirements compared to their high-field counterparts. Portable CT and ultrasound solutions are also gaining traction, enabling point-of-care assessments in ambulatory settings and challenging traditional radiology workflows. Meanwhile, software platforms supporting cloud-based image sharing and tele-radiology have accelerated cross-institutional collaboration, overcoming capacity constraints exacerbated by the pandemic.

Regulatory frameworks are evolving in parallel, with expedited pathways for AI and contrast-enhanced studies, fostering faster time-to-market for innovative tools. Reimbursement models are shifting toward value-based care, encouraging adoption of techniques that demonstrate improved clinical outcomes and cost efficiency. As a result, manufacturers and healthcare providers must adapt by investing in R&D, forging partnerships across the imaging ecosystem, and realigning business models to leverage these seismic technological and policy changes.

Assessing the Cumulative Impact of US Tariffs in 2025

In 2025, newly implemented U.S. tariffs on medical imaging equipment have introduced a layer of complexity for manufacturers and healthcare providers alike. By increasing import duties on key components and finished devices, these measures have elevated capital expenditure requirements, prompting many institutions to reevaluate procurement strategies. For original equipment manufacturers, rising material costs have necessitated negotiations with suppliers and the exploration of alternate sourcing options to maintain competitive pricing.

This policy shift has also catalyzed a renewed emphasis on domestic production. Several global vendors are in advanced discussions to establish or expand local manufacturing facilities, aiming to mitigate supply-chain vulnerabilities and circumvent tariff-induced price hikes. In parallel, some healthcare networks are exploring group purchasing models to consolidate buying power and offset incremental costs.

While short-term challenges include potential delays in equipment deployment and budgetary constraints, the longer-term outlook suggests an opportunity for reshaping manufacturing footprints and fostering innovation within U.S.-based operations. Stakeholders that proactively adapt to these tariff dynamics-through supply-chain diversification, strategic alliances, and investment in local capabilities-will be better positioned to sustain growth in a more protectionist trade environment.

Key Segmentation Insights into Technology, Application, and End Users

A nuanced understanding of market segmentation is critical for identifying high-potential niches. From a technology standpoint, the landscape spans computerized tomography systems-both cone beam CT and the more widely adopted multislice CT-alongside magnetic resonance imaging platforms that include high-field power systems for advanced research and low-field power units for cost-sensitive settings. Positron emission tomography solutions such as integrated PET-CT and PET-MRI are revolutionizing metabolic and structural assessments, while ultrasound modalities ranging from traditional 2D to immersive 3D and real-time 4D imaging are expanding point-of-care capabilities.

Clinical applications further illustrate divergent growth vectors. Imaging for congenital disorders like spina bifida and tethered cord at pediatric centers demands specialized protocols, whereas degenerative conditions-primarily spinal stenosis and spondylosis-dominate outpatient and hospital utilization. Infectious indications such as discitis and epidural abscess benefit from advanced contrast MRI and PET hybrid modalities. Oncology imaging encompasses benign, metastatic, and primary tumors, necessitating versatile platforms, and trauma care continues to rely heavily on rapid CT assessment for dislocations and fractures.

End-user dynamics reveal that hospitals-both government-funded and private-remain the largest adopters, driven by comprehensive service portfolios. Diagnostic imaging centers and ambulatory surgical facilities are capitalizing on portable and hybrid systems to deliver efficient, cost-effective procedures. Research and academic institutions play a pivotal role in validating novel protocols and accelerating regulatory approval for next-generation modalities.

Critical Regional Dynamics Shaping Market Trends

Regional market dynamics exhibit distinct characteristics across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, reimbursement policies and established research networks drive demand for high-end hybrid systems and AI-augmented workflows, with private hospitals leading adoption. Conversely, regulatory harmonization within Europe facilitates cross-border technology transfer, while infrastructure gaps and variable funding in the Middle East & Africa underscore the need for portable, cost-efficient solutions.

Asia-Pacific presents a heterogeneous landscape: advanced markets such as Japan and Australia prioritize high-field MRI and integrated PET platforms, whereas emerging economies in Southeast Asia pursue local manufacturing partnerships and deploy low-field MRI and mobile CT units to meet rising diagnostic needs. Government initiatives focused on universal healthcare access are further accelerating investment in imaging infrastructure. Overall, regional strategies must account for reimbursement variability, infrastructure maturity, and local regulatory frameworks to optimize market entry and expansion.

Competitive Landscape: Profiles of Leading Industry Players

The competitive arena features a diverse array of established multinationals and specialized technology providers. One firm has pioneered surgical navigation tools that integrate real-time imaging for enhanced procedural accuracy. Another player is renowned for its preclinical magnetic resonance research systems, driving early-stage innovation. Several global imaging conglomerates offer comprehensive CT and MRI portfolios, combining multislice CT scanners with both high-field and low-field MRI units, alongside cutting-edge PET hybrid modalities.

Ultrasound specialists continue to expand their offerings, delivering 2D systems for routine diagnostics and evolving toward 3D and 4D platforms that support dynamic assessments in ambulatory settings. Established medical device manufacturers augment their imaging divisions with advanced biomaterials for implantable spinal solutions, while global healthcare technology firms integrate AI-driven software suites across CT, MRI, and ultrasound modalities.

In parallel, pharmaceutical and radiopharmaceutical companies are investing in targeted tracers to enhance spinal oncology imaging, collaborating with imaging vendors to co-develop protocols. Regional OEMs leverage extensive distribution networks to address mid-tier markets, ensuring accessibility in cost-sensitive geographies. This multifaceted competitive landscape underscores the importance of strategic partnerships, continuous R&D, and an adaptable product portfolio.

Actionable Recommendations to Navigate Emerging Opportunities

To thrive amid shifting dynamics, industry leaders should prioritize several strategic initiatives. First, investing in hybrid imaging platforms that consolidate structural and functional modalities will address the growing demand for comprehensive diagnostics. Second, diversifying supply chains through local manufacturing alliances and strategic sourcing partnerships can mitigate tariff impacts and reduce time-to-deployment.

Furthermore, adopting cloud-based image management and AI-driven analytics will enhance workflow efficiency and support value-based care reimbursement models. Stakeholders should also intensify collaboration with regulatory bodies to secure expedited approvals for next-generation technologies. In parallel, developing tailored solutions for emerging regions-such as low-field MRI in underserved markets and portable CT for ambulatory centers-will unlock new growth corridors.

Finally, fostering educational programs and joint research initiatives with academic institutions will accelerate protocol validation and drive end-user adoption. By executing these recommendations, organizations can position themselves at the forefront of spinal imaging innovation and capture sustainable market share.

Conclusion: Charting the Future Course for Spinal Imaging

The spinal imaging market is marked by rapid technological innovation, evolving policy landscapes, and diverse end-user requirements. Through an integrated analysis of segmentation patterns, tariff influences, regional dynamics, and competitive positioning, it is clear that organizations must engage in agile strategy development. Embracing hybrid modalities, reinforcing supply-chain resilience, and leveraging digital health tools will be essential for delivering enhanced clinical outcomes and maintaining financial viability. As stakeholders navigate these complexities, cross-sector collaboration and a relentless focus on patient-centric solutions will define the leaders of tomorrow’s spinal imaging ecosystem.

Market Segmentation & Coverage

This research report categorizes the Spinal Imaging Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Computerized Tomography
    • Cone Beam CT
    • Multislice CT
  • Magnetic Resonance Imaging
    • High-Field Power MRI
    • Low-Field Power MRI
  • Positron Emission Tomography
    • PET-CT
    • PET-MRI
  • Ultrasound
    • 2D Ultrasound
    • 3D Ultrasound
    • 4D Ultrasound
  • Congenital Disorders
    • Spina Bifida
    • Tethered Cord
  • Degenerative Disorders
    • Spinal Stenosis
    • Spondylosis
  • Infections
    • Discitis
    • Epidural Abscess
  • Oncology
    • Benign Tumors
    • Metastatic Tumors
    • Primary Tumors
  • Trauma
    • Dislocations
    • Fractures
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Hospitals
    • Government Hospitals
    • Private Hospitals
  • Research And Academic Institutions

This research report categorizes the Spinal Imaging Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Spinal Imaging Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 7D Surgical
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • Invibio Ltd.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Narang Medical Limited
  • Novartis AG
  • NuVasive, Inc.
  • Sanofi S.A.
  • Shimadzu Corporation
  • Siemens Healthineers AG

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Spinal Imaging Market, by Technology
8.1. Introduction
8.2. Computerized Tomography
8.2.1. Cone Beam CT
8.2.2. Multislice CT
8.3. Magnetic Resonance Imaging
8.3.1. High-Field Power MRI
8.3.2. Low-Field Power MRI
8.4. Positron Emission Tomography
8.4.1. PET-CT
8.4.2. PET-MRI
8.5. Ultrasound
8.5.1. 2D Ultrasound
8.5.2. 3D Ultrasound
8.5.3. 4D Ultrasound
9. Spinal Imaging Market, by Application
9.1. Introduction
9.2. Congenital Disorders
9.2.1. Spina Bifida
9.2.2. Tethered Cord
9.3. Degenerative Disorders
9.3.1. Spinal Stenosis
9.3.2. Spondylosis
9.4. Infections
9.4.1. Discitis
9.4.2. Epidural Abscess
9.5. Oncology
9.5.1. Benign Tumors
9.5.2. Metastatic Tumors
9.5.3. Primary Tumors
9.6. Trauma
9.6.1. Dislocations
9.6.2. Fractures
10. Spinal Imaging Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Diagnostic Imaging Centers
10.4. Hospitals
10.4.1. Government Hospitals
10.4.2. Private Hospitals
10.5. Research And Academic Institutions
11. Americas Spinal Imaging Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Spinal Imaging Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Spinal Imaging Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. 7D Surgical
14.3.2. Bruker Corporation
14.3.3. Canon Medical Systems Corporation
14.3.4. FUJIFILM Holdings Corporation
14.3.5. GE Healthcare
14.3.6. Hitachi, Ltd.
14.3.7. Invibio Ltd.
14.3.8. Koninklijke Philips N.V.
14.3.9. Medtronic PLC
14.3.10. Narang Medical Limited
14.3.11. Novartis AG
14.3.12. NuVasive, Inc.
14.3.13. Sanofi S.A.
14.3.14. Shimadzu Corporation
14.3.15. Siemens Healthineers AG
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. SPINAL IMAGING MARKET MULTI-CURRENCY
FIGURE 2. SPINAL IMAGING MARKET MULTI-LANGUAGE
FIGURE 3. SPINAL IMAGING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPINAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPINAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPINAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPINAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SPINAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SPINAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SPINAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SPINAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPINAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPINAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPINAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPINAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPINAL IMAGING MARKET SIZE, BY MULTISLICE CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPINAL IMAGING MARKET SIZE, BY HIGH-FIELD POWER MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPINAL IMAGING MARKET SIZE, BY LOW-FIELD POWER MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPINAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPINAL IMAGING MARKET SIZE, BY PET-MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPINAL IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPINAL IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPINAL IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPINAL IMAGING MARKET SIZE, BY SPINA BIFIDA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPINAL IMAGING MARKET SIZE, BY TETHERED CORD, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPINAL IMAGING MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPINAL IMAGING MARKET SIZE, BY SPONDYLOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPINAL IMAGING MARKET SIZE, BY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPINAL IMAGING MARKET SIZE, BY DISCITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPINAL IMAGING MARKET SIZE, BY EPIDURAL ABSCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPINAL IMAGING MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPINAL IMAGING MARKET SIZE, BY METASTATIC TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPINAL IMAGING MARKET SIZE, BY PRIMARY TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPINAL IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPINAL IMAGING MARKET SIZE, BY DISLOCATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPINAL IMAGING MARKET SIZE, BY FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPINAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPINAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SPINAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SPINAL IMAGING MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SPINAL IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SPINAL IMAGING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. CANADA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CANADA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 96. CANADA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 97. CANADA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 98. CANADA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 99. CANADA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 101. CANADA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 102. CANADA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 103. CANADA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 104. CANADA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 105. CANADA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. CANADA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES SPINAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. CHINA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. CHINA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 163. CHINA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 164. CHINA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 165. CHINA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 166. CHINA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CHINA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 168. CHINA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 169. CHINA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 170. CHINA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 171. CHINA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 172. CHINA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. CHINA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. INDIA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. INDIA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 176. INDIA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 177. INDIA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 178. INDIA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 179. INDIA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. INDIA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 181. INDIA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 182. INDIA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 183. INDIA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 184. INDIA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 185. INDIA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. INDIA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. JAPAN SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. JAPAN SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 202. JAPAN SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 203. JAPAN SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 204. JAPAN SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 205. JAPAN SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. JAPAN SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 207. JAPAN SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 209. JAPAN SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 210. JAPAN SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 211. JAPAN SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. JAPAN SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. THAILAND SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. THAILAND SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 280. THAILAND SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 281. THAILAND SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 282. THAILAND SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 283. THAILAND SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 285. THAILAND SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 289. THAILAND SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA SPINAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 318. DENMARK SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. DENMARK SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 320. DENMARK SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 321. DENMARK SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 322. DENMARK SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 323. DENMARK SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. DENMARK SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 325. DENMARK SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 326. DENMARK SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 327. DENMARK SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 328. DENMARK SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 329. DENMARK SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. DENMARK SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. EGYPT SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. EGYPT SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 333. EGYPT SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 334. EGYPT SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 335. EGYPT SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 336. EGYPT SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. EGYPT SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 338. EGYPT SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 339. EGYPT SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 340. EGYPT SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 341. EGYPT SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD MILLION)
TABLE 342. EGYPT SPINAL IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. EGYPT SPINAL IMAGING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 344. FINLAND SPINAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 345. FINLAND SPINAL IMAGING MARKET SIZE, BY COMPUTERIZED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 346. FINLAND SPINAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 347. FINLAND SPINAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 348. FINLAND SPINAL IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 349. FINLAND SPINAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. FINLAND SPINAL IMAGING MARKET SIZE, BY CONGENITAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 351. FINLAND SPINAL IMAGING MARKET SIZE, BY DEGENERATIVE DISORDERS, 2018-2030 (USD MILLION)
TABLE 352. FINLAND SPINAL IMAGING MARKET SIZE, BY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 353. FINLAND SPINAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 354. FINLAND SPINAL IMAGING MARKET SIZE, BY TRAUMA, 2018-2030 (USD

Companies Mentioned

  • 7D Surgical
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • Invibio Ltd.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Narang Medical Limited
  • Novartis AG
  • NuVasive, Inc.
  • Sanofi S.A.
  • Shimadzu Corporation
  • Siemens Healthineers AG

Methodology

Loading
LOADING...